Corrigendum to AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons, [Neurobioly of Disease (2014) 62, 489-507] DOI: 10.1016/j.nbd.2013.10.018;AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons

Neurobiology of Disease

Volumn 62, Issue , 2014, Pages 489-507

  Amadoro, G ^a,b   Corsetti, V ^b   Florenzano, F ^b,c   Atlante, A ^c   Ciotti, M T ^c   Mongiardi, M P ^c   Bussani, R ^d   Nicolin, V ^e   Nori, S L ^f   Campanella, M ^b,g   Calissano, P ^b  

^a INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

^f UNIVERSITY OF SALERNO   (Italy)

^g ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Alzheimer's Disease (AD); Autophagy; Mitochondrial dynamics; Neurodegeneration; Synapse(s)

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMYLOID BETA PROTEIN; CELL MARKER; ISOPROTEIN; LC3 PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; BIOENERGY; BRAIN NERVE CELL; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; EMBRYO; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MOLECULAR WEIGHT; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUALITY CONTROL; SYNAPSE;

(CARBONYL CYANIDE 4-(TRIFLUOROMETHOXY)PHENYLHYDRAZONE); AD; ADENINE NUCLEOTIDE TRANSLOCATOR-1; ALZHEIMER'S DISEASE; ALZHEIMER'S DISEASE (AD); AMYLOID BETA; AMYLOID PRECURSOR PROTEIN; ANT-1; APP; AUTOPHAGY; AΒ; BAF-A1; BAFILOMYCIN A1; CHLOROQUINE; CITRATE SYNTHASE; COX; CQ; CS; CYTOCHROME C OXIDASE; FAD; FAMILIAR ALZHEIMER'S DISEASE; FCCP; MICROTUBULES; MITOCHONDRIAL DNA; MITOCHONDRIAL DYNAMICS; MOI; MT; MTDNA; MULTIPLICITY OF INFECTION; NEURODEGENERATION; NH(2)-HUMAN TAU FRAGMENT OF 20-22KDA; NH(2)-TAU FRAGMENT; NH(2)HTAU; PARKINSON'S DISEASE; PD; SYNAPSE(S); Α-SYN; Α-SYNUCLEIN;

ALZHEIMER DISEASE; CELL LINE, TUMOR; HIPPOCAMPUS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; NEURONS; PEPTIDE FRAGMENTS; SYNAPSES; TAU PROTEINS;

EID: 84888223184     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2014.11.010     Document Type: Erratum

References (167)

1. Amadoro G., Serafino A.L., Barbato C., Ciotti M.T., Sacco A., Calissano P., Canu N. Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ. 2004, 11(2):217-230.
2. Amadoro G., Ciotti M.T., Costanzi M., Cestari V., Calissano P., Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(8):2892-2897.
3. 2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. J. Alzheimers Dis. 2010, 21(2):445-470.
4. Amadoro G., Corsetti V., Atlante A., Florenzano F., Capsoni S., Bussani R., Mercanti D., Calissano P. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration. Neurobiol. Aging 2012, 33(4):833.
5. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2012, 10.1038/cdd.2012.81.
6. Atlante A., de Bari L., Bobba A., Marra E., Calissano P., Passarella S. Cytochrome c, released from cerebellar granule cells undergoing apoptosis or excytotoxic death, can generate protonmotive force and drive ATP synthesis in isolated mitochondria. J. Neurochem. 2003, 86(3):591-604. (Aug).
7. Atlante A., Amadoro G., Bobba A., de Bari L., Corsetti V., Pappalardo G., Marra E., Calissano P., Passarella S. A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator. Biochim. Biophys. Acta 2008, 1777(10):1289-1300.
8. Baloyannis S.J. Mitochondrial alterations in Alzheimer's disease. J. Alzheimers Dis. 2006, 9(2):119-126. (Review).
9. Baloyannis S.J. Mitochondria are related to synaptic pathology in Alzheimer's disease. Int. J. Alzheimers Dis. 2011, 2011:305395.
10. Barrientos A. In vivo and in organello assessment of OXPHOS activities. Methods 2002, 26(4):307-316. (Review).
11. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., Gräber S., Kovacs I., Lee W.D., Waggoner J., Cui J., White A.D., Bossy B., Martinou J.C., Youle R.J., Lipton S.A., Ellisman M.H., Perkins G.A., Bossy-Wetzel E. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J. 2006, 25(16):3900-3911.
12. Batlevi Y., La Spada A.R. Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging. Neurobiol. Dis. 2011, 43(1):46-51. (Review).
13. Bjørkøy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., Stenmark H., Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 2005, 171(4):603-614.
14. 2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease. Biochim. Biophys. Acta 2013, (pii: S0005-2728(13)00072-8. [Epub ahead of print] Apr 11). 10.1016/j.bbabio.2013.04.001.
15. Boland B., Kumar A., Lee S., Platt F.M., Wegiel J., Yu W.H., Nixon R.A. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 2008, 28(27):6926-6937.
16. Bonda D.J., Wang X., Perry G., Smith M.A., Zhu X. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs Aging 2010, 27(3):181-192. (Review).
17. Cai Q., Zakaria H.M., Simone A., Sheng Z.H. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr. Biol. 2012, 22(6):545-552.
18. Calkins M.J., Reddy P.H. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: implications for impaired mitochondrial biogenesis and synaptic damage. Biochim. Biophys. Acta 2011, 1812(9):1182-1189.
19. Calkins M.J., Manczak M., Mao P., Shirendeb U., Reddy P.H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2011, 20(23):4515-4529.
20. Campanella M., Seraphim A., Abeti R., Casswell E., Echave P., Duchen M.R. IF1, the endogenous regulator of the F(1)F(o)-ATP synthase, defines mitochondrial volume fraction in HeLa cells by regulating autophagy. Biochim. Biophys. Acta 2009, 1787(5):393-401.
21. Campello S., Scorrano L. Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep. 2010, 11(9):678-684. (Review).
22. Cha M.Y., Han S.H., Son S.M., Hong H.S., Choi Y.J., Byun J., Mook-Jung I. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 2012, 7(4):e34929.
23. Chakrabarti L., Eng J., Ivanov N., Garden G.A., La Spada A.R. Autophagy activation and enhanced mitophagy characterize the Purkinje cells of pcd mice prior to neuronal death. Mol. Brain 2009, 2:24.
24. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125(7):1241-1252. (Review).
25. Chan N.C., Salazar A.M., Pham A.H., Sweredoski M.J., Kolawa N.J., Graham R.L., Hess S., Chan D.C. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 2011, 20(9):1726-1737.
26. Chee F.C., Mudher A., Cuttle M.F., Newman T.A., MacKay D., Lovestone S., Shepherd D. Over-expression of tau results in defective synaptic transmission in Drosophila neuromuscular junctions. Neurobiol. Dis. 2005, 20(3):918-928.
27. Chen H., Chan D.C. Critical dependence of neurons on mitochondrial dynamics. Curr. Opin. Cell Biol. 2006, 18(4):453-459. (Review).
28. Chen H., Chan D.C. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum. Mol. Genet. 2009, 18(R2):R169-R176. (Review).
29. Cherra S.J., Chu C.T. Autophagy in neuroprotection and neurodegeneration: a question of balance. Future Neurol. 2008, 3(3):309-323.
30. Cheung Z.H., Ip N.Y. Autophagy deregulation in neurodegenerative diseases - recent advances and future perspectives. J. Neurochem. 2011, 118(3):317-325. (Review).
31. Cheung E.C., Melanson-Drapeau L., Cregan S.P., Vanderluit J.L., Ferguson K.L., McIntosh W.C., Park D.S., Bennett S.A., Slack R.S. Apoptosis-inducing factor is a key factor in neuronal cell death propagated by BAX-dependent and BAX-independent mechanisms. J. Neurosci. 2005, 25(6):1324-1334.
32. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal, injury. Science 2009, 324:102-105.
33. Cho M.H., Kim D.H., Choi J.E., Chang E.J., Seung-Yongyoon Increased phosphorylation of dynamin-related protein 1 and mitochondrial fission in okadaic acid-treated neurons. Brain Res. 2012, 1454:100-110.
34. Choubey V., Safiulina D., Vaarmann A., Cagalinec M., Wareski P., Kuum M., Zharkovsky A., Kaasik A. Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy. J. Biol. Chem. 2011, 286(12):10814-10824.
35. Chu C.T. Autophagic stress in neuronal injury and disease. J. Neuropathol. Exp. Neurol. 2006, 65(5):423-432. (Review).
36. Chu C.T., Zhu J., Dagda R. Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy 2007, 3(6):663-666.
37. Colaço R., Moreno N., Feijó J.A. On the fast lane: mitochondria structure, dynamics and function in growing pollen tubes. J. Microsc. 2012, 247(1):106-118. (Jul).
38. Corsetti V., Amadoro G., Gentile A., Capsoni S., Ciotti M.T., Cencioni M.T., Atlante A., Canu N., Rohn T.T., Cattaneo A., Calissano P. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models. Mol. Cell. Neurosci. 2008, 38(3):381-392.
39. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell Biol. 2002, 158(3):507-517.
40. Dagda R.K., Cherra S.J., Kulich S.M., Tandon A., Park D., Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol. Chem. 2009, 284(20):13843-13855.
41. Dagda R.K., Gusdon A.M., Pien I., Strack S., Green S., Li C., Van Houten B., Cherra S.J., Chu C.T. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ. 2011, 18(12):1914-1923.
42. Dasuri K., Zhang L., Keller J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic. Biol. Med. 2012, (pii: S0891-5849(12)01141-0. [Epub ahead of print]). 10.1016/j.freeradbiomed.2012.09.016.
43. David D.C., Hauptmann S., Scherping I., Schuessel K., Keil U., Rizzu P., Ravid R., Dröse S., Brandt U., Müller W.E., Eckert A., Götz J. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol. Chem. 2005, 280(25):23802-23814.
44. Denison S.R., Wang F., Becker N.A., Schüle B., Kock N., Phillips L.A., Klein C., Smith D.I. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 2003, 22(51):8370-8378.
45. Dias-Santagata D., Fulga T.A., Duttaroy A., Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 2007, 117(1):236-245.
46. Dixit R., Ross J.L., Goldman Y.E., Holzbaur E.L. Differential regulation of dynein and kinesin motor proteins by tau. Science 2008, 319(5866):1086-1089.
47. Dolan P.J., Johnson G.V. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol. Chem. 2010, 285(29):21978-21987.
48. Du H., Guo L., Yan S., Sosunov A.A., McKhann G.M., Yan S.S. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(43):18670-18675.
49. Du H., Guo L., Yan S.S. Synaptic mitochondrial pathology in Alzheimer's disease. Antioxid. Redox Signal. 2012, 16(12):1467-1475.
50. Dubey M., Chaudhury P., Kabiru H., Shea T.B. Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability. Cell Motil. Cytoskeleton 2008, 65(2):89-99.
51. Duboff B., Götz J., Feany M.B. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 2012, 75(4):618-632.
52. Eckert A., Schmitt K., Götz J. Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity. Alzheimers Res. Ther. 2011, 3(2):15.
53. Falcón-Pérez J.M., Nazarian R., Sabatti C., Dell'Angelica E.C. Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J. Cell Sci. 2005, 118(Pt 22):5243-5255.
54. Fernández-Vizarra E., Enríquez J.A., Pérez-Martos A., Montoya J., Fernández-Silva P. Tissue-specific differences in mitochondrial activity and biogenesis. Mitochondrion 2011, 11(1):207-213.
55. Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., Scorrano L. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 2006, 126(1):177-189.
56. Fu X., Wan S., Lyu Y.L., Liu L.F., Qi H. Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 2008, 3(4):e2009.
57. García-Sierra F., Mondragón-Rodríguez S., Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer's disease. J. Alzheimers Dis. 2008, 14(4):401-419. (Review).
58. Gegg M.E., Cooper J.M., Chau K.Y., Rojo M., Schapira A.H., Taanman J.W. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/Parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 2010, 19(24):4861-4870.
59. Geisler S., Holmström K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 2010, 12(2):119-131.
60. Gilley J., Seereeram A., Ando K., Mosely S., Andrews S., Kerschensteiner M., Misgeld T., Brion J.P., Anderton B., Hanger D.P., Coleman M.P. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Neurobiol. Aging 2012, 33(3):621. (e1-621.e15).
61. Glauser L., Sonnay S., Stafa K., Moore D.J. Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1. J. Neurochem. 2011, 118(4):636-645.
62. Gomes L.C., Di Benedetto G., Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 2011, 13(5):589-598.
63. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21(9):3017-3023.
64. Inoue K., Rispoli J., Kaphzan H., Klann E., Chen E.I., Kim J., Komatsu M., Abeliovich A. Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway. Mol. Neurodegener. 2012, 7(1):48.
65. Ittner L.M., Ke Y.D., Götz J. Phosphorylated tau interacts with c-Jun N-terminal kinase-interacting protein 1 (JIP1) in Alzheimer disease. J Biol. Chem. 2009, 284(31):20909-20916.
66. Jahani-Asl A., Pilon-Larose K., Xu W., MacLaurin J.G., Park D.S., McBride H.M., Slack R.S. The mitochondrial inner membrane GTPase, optic atrophy 1 (Opa1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. J Biol. Chem. 2011, 286(6):4772-4782.
67. Jin S.M., Lazarou M., Wang C., Kane L.A., Narendra D.P., Youle R.J. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 2010, 191(5):933-942.
68. Joselin A.P., Hewitt S.J., Callaghan S.M., Kim R.H., Chung Y.H., Mak T.W., Shen J., Slack R.S., Park D.S. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons. Hum. Mol. Genet. 2012, 21(22):4888-4903.
69. Kabeya Y., Mizushima N., Ueno T., Yamamoto A., Kirisako T., Noda T., Kominami E., Ohsumi Y., Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19(21):5720-5728. (Erratum in: EMBO J. Sep 22(17):4577).
70. Kanaan N.M., Morfini G.A., LaPointe N.E., Pigino G.F., Patterson K.R., Song Y., Andreadis A., Fu Y., Brady S.T., Binder L.I. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 2011, 31(27):9858-9868.
71. Kanaan N.M., Morfini G., Pigino G., LaPointe N.E., Andreadis A., Song Y., Leitman E., Binder L.I., Brady S.T. Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol. Aging 2012, 33(4):826. (e15-30).
72. Kane L.A., Youle R.J. PINK1 and Parkin flag Miro to direct mitochondrial traffic. Cell 2011, 147(4):721-723.
73. Karbowski M., Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol. 2012, 123(2):157-171. (Review).
74. Karbowski M., Youle R.J. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr. Opin. Cell Biol. 2011, 23(4):476-482. (Review).
75. Kirby D.M., Thorburn D.R., Turnbull D.M., Taylor R.W. Biochemical assays of respiratory chain complex activity. Methods Cell Biol. 2007, 80:93-119. (Review).
76. Kirkin V., Lamark T., Johansen T., Dikic I. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. Autophagy 2009, 5(5):732-733.
77. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., Bamber B.A., Bassham D.C., Bergamini E., Bi X., Biard-Piechaczyk M., Blum J.S., Bredesen D.E., Brodsky J.L., Brumell J.H., Brunk U.T., Bursch W., Camougrand N., Cebollero E., Cecconi F., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008, 4(2):151-175. (Review).
78. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., Ahn H.J., Ait-Mohamed O., Ait-Si-Ali S., Akematsu T., Akira S., Al-Younes H.M., Al-Zeer M.A., Albert M.L., Albin R.L., Alegre-Abarrategui J., Aleo M.F., Alirezaei M., Almasan A., Almonte-Becerril M., Amano A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8(4):445-544.
79. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008, 9(7):505-518. (Review).
80. Koch J., Pranjic K., Huber A., Ellinger A., Hartig A., Kragler F., Brocard C. PEX11 family members are membrane elongation factors that coordinate peroxisome proliferation and maintenance. J. Cell Sci. 2010, 123(Pt 19):3389-3400.
81. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., Mizushima N., Iwata J., Ezaki J., Murata S., Hamazaki J., Nishito Y., Iemura S., Natsume T., Yanagawa T., Uwayama J., Warabi E., Yoshida H., Ishii T., Kobayashi A., Yamamoto M., Yue Z., Uchiyama Y., Kominami E., Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131(6):1149-1163.
82. Kopeikina K.J., Carlson G.A., Pitstick R., Ludvigson A.E., Peters A., Luebke J.I., Koffie R.M., Frosch M.P., Hyman B.T., Spires-Jones T.L. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am. J. Pathol. 2011, 179(4):2071-2082.
83. Kunz W.S., Kudin A., Vielhaber S., Elger C.E., Attardi G., Villani G. Flux control of cytochrome c oxidase in human skeletal muscle. J. Biol. Chem. 2000, 275(36). (27741-22745).
84. Lee J., Giordano S., Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem. J. 2012, 441(2):523-540.
85. Lee S.H., Kim K.R., Ryu S.Y., Son S., Hong H.S., Mook-Jung I., Lee S.H., Ho W.K. Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease. J. Neurosci. 2012, 32(17):5953-5963.
86. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119(6):873-887.
87. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
88. Liu S., Sawada T., Lee S., Yu W., Silverio G., Alapatt P., Millan I., Shen A., Saxton W., Kanao T., Takahashi R., Hattori N., Imai Y., Lu B. Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet. 2012, 8(3):e1002537.
89. Magnani E., Fan J., Gasparini L., Golding M., Williams M., Schiavo G., Goedert M., Amos L.A., Spillantini M.G. Interaction of tau protein with the dynactin complex. EMBO J. 2007, 26(21):4546-4554.
90. Magrané J., Sahawneh M.A., Przedborski S., Estévez Á.G., Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J. Neurosci. 2012, 32(1):229-242.
91. Manczak M., Reddy P.H. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 2012, 21(11):2538-2547.
92. Manczak M., Calkins M.J., Reddy P.H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 2011, 20(13):2495-2509.
93. Manthorpe M., Fagnani R., Skaper S.D., Varon S. An automated colorimetric microassay for neuronotrophic factors. Brain Res. 1986, 390:191-198.
94. Mazat J.P., Rossignol R., Malgat M., Rocher C., Faustin B., Letellier T. What do mitochondrial diseases teach us about normal mitochondrial functions. .that we already knew: threshold expression of mitochondrial defects. Biochim. Biophys. Acta 2001, 1504(1):20-30. (Review).
95. Misko A., Jiang S., Wegorzewska I., Milbrandt J., Baloh R.H. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. 2010, 30(12):4232-4240.
96. Moreira P.I., Siedlak S.L., Wang X., Santos M.S., Oliveira C.R., Tabaton M., Nunomura A., Szweda L.I., Aliev G., Smith M.A., Zhu X., Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 2007, 3(6):614-615.
97. Moreira P.I., Siedlak S.L., Wang X., Santos M.S., Oliveira C.R., Tabaton M., Nunomura A., Szweda L.I., Aliev G., Smith M.A., Zhu X., Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2007, 66(6):525-532. (Erratum in: J Neuropathol Exp Neurol. 66(7):674.).
98. Muntané G., Dalfó E., Martinez A., Ferrer I. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies. Neuroscience 2008, 152:913-923.
99. Nakamura T., Lipton S.A. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases. Apoptosis 2010, 15(11):1354-1363. (Review).
100. Nakamura K., Nemani V.M., Azarbal F., Skibinski G., Levy J.M., Egami K., Munishkina L., Zhang J., Gardner B., Wakabayashi J., Sesaki H., Cheng Y., Finkbeiner S., Nussbaum R.L., Masliah E., Edwards R.H. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J.Biol. Chem. 2011, 286(23):20710-20726.
101. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183(5):795-803.
102. Narendra D.P., Jin S.M., Tanaka A., Suen D.F., Gautier C.A., Shen J., Cookson M.R., Youle R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8(1):e1000298.
103. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148(6):1145-1159. (Review).
104. Pacheco C.D., Elrick M.J., Lieberman A.P. Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum. Mol. Genet. 2009, 18(5):956-965.
105. Pallotti F., Lenaz G. Isolation and subfractionation of mitochondria from animal cells and tissue culture lines. Methods Cell Biol. 2001, 65:1-35.
106. Palmer C.S., Osellame L.D., Stojanovski D., Ryan M.T. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell. Signal. 2011, 23(10):1534-1545.
107. Pawlyk A.C., Giasson B.I., Sampathu D.M., Perez F.A., Lim K.L., Dawson V.L., Dawson T.M., Palmiter R.D., Trojanowski J.Q., Lee V.M. Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. J. Biol. Chem. 2003, 278(48):48120-48128.
108. Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., Small S., Spencer B., Rockenstein E., Levine B., Wyss-Coray T. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 2008, 118(6):2190-2199.
109. Quintanilla R.A., Matthews-Roberson T.A., Dolan P.J., Johnson G.V. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J Biol. Chem. 2009, 284(28):18754-18766.
110. Quintanilla R.A., Dolan P.J., Jin Y.N., Johnson G.V. Truncated tau and Aβ cooperatively impair mitochondria in primary neurons. Neurobiol. Aging 2012, 33(3):619. (e25-35).
111. Reddy P.H. Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Res. 2011, 1415:136-148. (Review).
112. Reddy P.H., Beal M.F. Are mitochondria critical in the pathogenesis of Alzheimer's disease?. Brain Res. Brain Res. Rev. 2005, 49(3):618-632. (Review).
113. Reddy P.H., Tripathi R., Troung Q., Tirumala K., Reddy T.P., Anekonda V., Shirendeb U.P., Calkins M.J., Reddy A.P., Mao P., Manczak M. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 2012, 1822(5):639-649.
114. Rhein V., Song X., Wiesner A., Ittner L.M., Baysang G., Meier F., Ozmen L., Bluethmann H., Dröse S., Brandt U., Savaskan E., Czech C., Götz J., Eckert A. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(47):20057-20062.
115. Rintoul G.L., Reynolds I.J. Mitochondrial trafficking and morphology in neuronal injury. Biochim. Biophys. Acta 2010, 1802(1):143-150. (Review).
116. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994, 228(1):35-351. (Review).
117. Santos R.X., Correia S.C., Wang X., Perry G., Smith M.A., Moreira P.I., Zhu X.A. Synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J. Alzheimers Dis. 2010, 20(Suppl. 2):S401-S412. (Review).
118. Scherz-Shouval R., Elazar Z. ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007, 17(9):422-427.
119. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70(6):1033-1053. (Review).
120. Selfridge J.E., Lezi E., Lu J., Swerdlow R.H. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol. Dis. 2013, 51:3-12.
121. Sheng Z.H., Cai Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 2012, 13(2):77-93. (Review).
122. Sheng B., Wang X., Su B., Lee H.G., Casadesus G., Perry G., Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem. 2012, 120(3):419-429.
123. Solano R.M., Casarejos M.J., Gómez A., Perucho J., de Yébenes J.G., Mena M.A. Parkin null cortical neuronal/glial cultures are resistant to amyloid-β1-42 toxicity: a role for autophagy?. J. Alzheimers Dis. 2012, ([Epub ahead of print] PMID:22785397 Jul 11).
124. Song Z., Chen H., Fiket M., Alexander C., Chan D.C. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 2007, 178(5):749-755.
125. Soto A.M., Sonnenschein C. The role of estrogen on the proliferation of human breast tumor cells (MCF-7). J. Steroid Biochem. 1985, 23:87-94.
126. Springer W., Kahle P.J. Regulation of PINK1-Parkin-mediated mitophagy. Autophagy 2011, 7(3):266-278. (Review).
127. Srere P.A. Studies on purified citrate-enzymes: metabolic interpretations. Biochem. Soc. Symp. 1968, 27:11-21.
128. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 2002, 156(6):1051-1063.
129. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307(5713):1282-1288.
130. Stoothoff W., Jones P.B., Spires-Jones T.L., Joyner D., Chhabra E., Bercury K., Fan Z., Xie H., Bacskai B., Edd J., Irimia D., Hyman B.T. Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport. J. Neurochem. 2009, 111(2):417-427.
131. Tan Z., Sun X., Hou F.S., Oh H.W., Hilgenberg L.G., Ho E.M., van Leeuwen F.W., Smith M.A., O'Dowd D.K., Schreiber S.S. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Cell Death Differ. 2007, 14(10):1721-1732.
132. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191(7):1367-1380.
133. Thies E., Mandelkow E.M. Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. J. Neurosci. 2007, 27(11):2896-2907.
134. Tolkovsky A.M. Mitophagy. Biochim. Biophys. Acta 2009, 1793(9):1508-1515. (Review).
135. Trushina E., Nemutlu E., Zhang S., Christensen T., Camp J., Mesa J., Siddiqui A., Tamura Y., Sesaki H., Wengenack T.M., Dzeja P.P., Poduslo J.F. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One 2012, 7(2):e32737.
136. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim. Biophys. Acta 2008, 1777(9):1092-1097. (Review).
137. Van Humbeeck C., Cornelissen T., Hofkens H., Mandemakers W., Gevaert K., De Strooper B., Vandenberghe W. Parkin interacts with Ambra1 to induce mitophagy. J. Neurosci. 2011, 31(28):10249-10261.
138. Van Laar V.S., Berman S.B. The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease. Neurobiol. Dis. 2013, 51:43-55.
139. Van Laar V.S., Arnold B., Cassady S.J., Chu C.T., Burton E.A., Berman S.B. Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum. Mol. Genet. 2011, 20(5):927-940.
140. Vande Velde C., McDonald K.K., Boukhedimi Y., McAlonis-Downes M., Lobsiger C.S., Bel Hadj S., Zandona A., Julien J.P., Shah S.B., Cleveland D.W. Misfolded SOD1 associated with motor neuron mitochondria alters mitochondrial shape and distribution prior to clinical onset. PLoS One 2011, 6(7):e22031.
141. Verstreken P., Ly C.V., Venken K.J., Koh T.W., Zhou Y., Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005, 47(3):365-378.
142. Viscomi M.T., D'Amelio M., Cavallucci V., Latini L., Bisicchia E., Nazio F., Fanelli F., Maccarrone M., Moreno S., Cecconi F., Molinari M. Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage. Autophagy 2012, 8(2):222-235.
143. Vives-Bauza C., Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol. Med. 2011, 17(3):158-165.
144. Vives-Bauza C., de Vries R.L., Tocilescu M., Przedborski S. PINK1/Parkin direct mitochondria to autophagy. Autophagy 2010, 6(2):315-316.
145. Volontè C., Ciotti M.T., Battistini L. Development of a method for measuring cell number: application to CNS primary neuronal culture. Cytometry 1994, 17:274-276.
146. Wang Q.J., Ding Y., Kohtz D.S., Mizushima N., Cristea I.M., Rout M.P., Chait B.T., Zhong Y., Heintz N., Yue Z. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci. 2006, 26(33):1. (Erratum in: J Neurosci. 26(33):1).
147. Wang X., Su B., Fujioka H., Zhu X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol. 2008, 173:470-482.
148. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
149. Wang X., Su B., Zheng L., Perry G., Smith M.A., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Neurochem. 2009, 109(Suppl. 1):153.
150. Wang X., Winter D., Ashrafi G., Schlehe J., Wong Y.L., Selkoe D., Rice S., Steen J., LaVoie M.J., Schwarz T.L. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147(4):893-906.
151. Wang X., Petrie T.G., Liu Y., Liu J., Fujioka H., Zhu X. Parkinson's disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction. J. Neurochem. 2012, 121(5):830-839.
152. Wong A.S., Cheung Z.H., Ip N.Y. Molecular machinery of macroautophagy and its deregulation in diseases. Biochim. Biophys. Acta 2011, 1812(11):1490-1497.
153. Wong A.S., Lee R.H., Cheung A.Y., Yeung P.K., Chung S.K., Cheung Z.H., Ip N.Y. Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease. Nat. Cell Biol. 2011, 13(5):568-579. (Erratum in: Nat Cell Biol. 2011 13(6):734).
154. Wredenberg A., Wibom R., Wilhelmsson H., Graff C., Wiener H.H., Burden S.J., Oldfors A., Westerblad H., Larsson N.G. Increased mitochondrial mass in mitochondrial myopathy mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(23):15066-15071.
155. Xie W., Chung K.K. Alpha-synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson's disease. J. Neurochem. 2012, (Epub ahead of print). 10.1111/j.1471-4159.2012.07769.x.
156. Yoshii S.R., Kishi C., Ishihara N., Mizushima N. Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane. J. Biol. Chem. 2011, 286(22):19630-19640.
157. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 2011, 12(1):9-14. (Review).
158. Young-Collier K.J., McArdle M., Bennett J.P. The dying of the light: mitochondrial failure in Alzheimer's disease. J. Alzheimers Dis. 2012, 28(4):771-781.
159. Yu W., Sun Y., Guo S., Lu B. The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons. Hum. Mol. Genet. 2011, 20(16):3227-3240.
160. Yue Z., Friedman L., Komatsu M., Tanaka K. The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim. Biophys. Acta 2009, 1793(9):1496-1507. (Review).
161. Zeviani M., Gellera C., Antozzi C., Rimoldi M., Morandi L., Villani F., Tiranti V., DiDonato S. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA (Leu) (UUR). Lancet 1991, 338(8760):143-147.
162. Zhu J.H., Horbinski C., Guo F., Watkins S., Uchiyama Y., Chu C.T. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 2007, 170(1):75-86.
163. Zhu J., Dagda R.K., Chu C.T. Monitoring mitophagy in neuronal cell cultures. Methods Mol. Biol. 2011, 793:325-339.
164. Zhu J.H., Gusdon A.M., Cimen H., Van Houten B., Koc E., Chu C.T. Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP(+) toxicity: dual roles for ERK1/2. Cell Death Dis. 2012, 3:e312.
165. Zhu X., Perry G., Smith M.A., Wang X. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis. 2013, 33(Suppl 1):S253-S262. 10.3233/JAD-2012-129005.
166. Zinchuk V., Grossenbacher-Zinchuk O. Recent advances in quantitative colocalization analysis: focus on neuroscience. Prog. Histochem. Cytochem. 2009, 44(3):125-172. (Review).
167. Ziviani E., Whitworth A.J. How could Parkin-mediated ubiquitination of mitofusin promote mitophagy?. Autophagy 2010, 6(5). (Jul 1[Epub ahead of print]).